About Memo Therapeutics
Memo Therapeutics AG translate immune responses into superior medicines. Our best-in-class antibodies transform lives of patients with viral infections & cancer
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
Undisclosed
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
memo-therapeutics.com
Domain Registered Date
Nov 11, 2012
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $22,000,000 · Series-B+
startupintros.com
- Capital Raise
Raised $4,990,000 · Series-A
startupintros.com
- Milestone
Website domain registered
memo-therapeutics.com
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for Memo Therapeutics.
Funding History
Series-B+
· May 7, 2024
$22,000,000 startupintros.com
Series-A
· May 9, 2018
$4,990,000 startupintros.com
Founders & Leadership
Christoph Esslinger
Co-founder
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026